Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.600
+0.040 (1.56%)
Aug 22, 2025, 4:00 PM - Market closed

Eledon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
14.64-36.18-116.54-87.97-34.51-22.81
Upgrade
Depreciation & Amortization
0.360.360.370.370.20.18
Upgrade
Asset Writedown & Restructuring Costs
---48.65--
Upgrade
Loss (Gain) From Sale of Investments
-2.97-2.8-1.2---
Upgrade
Stock-Based Compensation
13.9213.126.558.157.93.17
Upgrade
Other Operating Activities
-97.47-30.4876.21--2.354.43
Upgrade
Change in Accounts Payable
7.637.75-2.62.082.14-0.04
Upgrade
Change in Other Net Operating Assets
-0.640.96-2.320.29-2.3-0.14
Upgrade
Operating Cash Flow
-64.53-47.27-39.53-28.42-28.91-15.21
Upgrade
Cash Acquisitions
-----11.04
Upgrade
Investment in Securities
-41.33-70.31-45.29---
Upgrade
Investing Cash Flow
-41.33-70.31-45.29--11.04
Upgrade
Issuance of Common Stock
85.57133.5233.02-014.38
Upgrade
Repurchase of Common Stock
------0.03
Upgrade
Other Financing Activities
-----0.45-
Upgrade
Financing Cash Flow
85.57133.5233.02--0.45109.58
Upgrade
Net Cash Flow
-20.315.94-51.8-28.42-29.36105.4
Upgrade
Free Cash Flow
-64.53-47.27-39.53-28.42-28.91-15.21
Upgrade
Free Cash Flow Per Share
-0.94-0.97-1.61-1.99-1.95-10.48
Upgrade
Levered Free Cash Flow
-33.25-21.4-24.47-13.85-15.33-4.01
Upgrade
Unlevered Free Cash Flow
-33.25-21.4-24.47-13.85-15.33-4.01
Upgrade
Change in Working Capital
6.998.71-4.922.37-0.15-0.18
Upgrade
Updated Aug 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q